why choose us

Clinical Trials Search

Showing 20,100 of 132,963 result(s)
Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Status: Completed

Condition: Immune Mediated Anemia

Interventions: Participants will receive fostamatinib 100 mg BID for 4 weeks.
On the 4-week evaluation, a) if cytopenia improves (hemoglobin =10 g;dL, plat

Date: 2022-08-12

Translating Anesthesia Care Throughout

Status: COMPLETED

Condition: Limited English Proficiency

Interventions: Translation extended beyond the preoperative area

Date: 2022-08-12

Trial of Diphenhydramine for Sleep in Children With Autism

Status: Completed

Condition: Autism

Interventions: 25mg (and up to 50mg) Diphenhydramine given orally

Date: 2022-08-12

Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia

Status: Completed

Condition: Acute Lymphoblastic Leukemia

Interventions: Adults, or patients ? 50 kg: 990 mg PO (by mouth) bis in die (BID, twice a day) Children, or patients < 50 kg: 50 mg;kg;day PO divided BI

Date: 2022-08-12

FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease

Status: Completed

Condition: Cognitive Dysfunction

Interventions: Exercise using the motion sensing devices and a tablet computer

Date: 2022-08-12

Virtual Reality and Meditation for Fibromyalgia

Status: Completed

Condition: Fibromyalgia

Interventions: Interventional

Date: 2022-08-12

Association Between Preoperative HALP and Immediate Postoperative Outcomes

Status: Completed

Condition: Hemoglobins
Albumins
Platelets
Lymphocytes
Morbidity
Mortality
Whipple

Interventions: Other: pantients undergoing pancreaticoduodenectomy
The study includes all the cases who underwent pancreaticoduodenectomy for carcinoma head of

Date: 2022-08-12

One-time Informed Consent for Research in Prison

Status: Completed

Condition: Informed Consent

Interventions: Interventional

Date: 2022-08-12

Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma

Status:

Condition: Relapsed or Refractory Multiple Myeloma

Interventions: Drug: Talquetamab
Talquetamab 0.01 milligrams/kilogram (mg/kg) and 0.06 mg/kg will be administered subcutaneously (SC) as 2 step-up doses, respec

Date: 2022-08-12

Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application

Status: Completed

Condition: Pregnancy Related
Preterm Birth

Interventions: Behavioral: MyHealthyPregnancy
MyHealthyPregnancy is a mobile application prescribed to expectant mothers in conjunction with normal prenatal car

Date: 2022-08-12